Cheryl Ho

21PUBLICATIONS
67CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyDeep learningCancer therapy (excl. chemotherapy and radiation therapy)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jun 26, 2026
Fusion of Clinical and Deep Learning Features for Predicting Pembrolizumab Monotherapy Response in Advanced Non-Small Cell Lung Cancer.

|Feb 21, 2025
Clinical Effectiveness and Cost-Effectiveness of Multigene Panel Sequencing in Advanced Melanoma: A Population-Level Real-World Target Trial Emulation.

Emanuel Krebs, Deirdre Weymann, Cheryl Ho

|Jan 25, 2025
Enhanced Lung Cancer Survival Prediction Using Semi-Supervised Pseudo-Labeling and Learning from Diverse PET/CT Datasets.

Mohammad R Salmanpour, Arman Gorji, Amin Mousavi

|Jan 24, 2025
A Canadian Perspective on Systemic Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma.

Anna Spreafico, Eric Winquist, Cheryl Ho

|Jan 11, 2025
Machine Learning and Computed Tomography Radiomics to Predict Disease Progression to Upfront Pembrolizumab Monotherapy in Advanced Non-Small-Cell Lung Cancer: A Pilot Study.

Ian Janzen, Cheryl Ho, Barbara Melosky

|Dec 06, 2024
Correction: Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management.

Ozgur Mete, Andrée Boucher, Kasmintan A Schrader

Pageof 4

Frequent Collaborators

6 joint publications

Barbara Melosky

5 joint publications

Bonnie Leung

4 joint publications

Aria Shokoohi

4 joint publications

Ren Yuan